This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundThe purpose of this study was to investigate whether circulating pyruvate kinase M2 (PKM2) levels are elevated in the peripheral blood and to assess their association with diagnosis and prognosis in patients with heartfailure (HF).Methods Patients with HF had higher PKM2 levels than controls (17.44.1 versus 7.82.3
Cardiacfunction was assessed by echocardiography at 2-, 4- and 6-weeks post-MI. Cardiac damage and structural remodeling were evaluated using circulating biomarkers of cardiacfunction and histological assessment.Results:ETX-258 was selected as a highly active siRNA for the treatment of heartfailure with a long duration of action.
Macrophage-specific NPM1 deletion reduced infarct size, promoted angiogenesis, and suppressed tissue fibrosis, in turn improving cardiacfunction and protecting against adverse cardiac remodeling after MI. NPM1 may serve as a promising prognostic biomarker and a valuable therapeutic target for heartfailure after MI.
Our study aimed to evaluate the expression of sodium–glucose cotransporter 2 (SGLT2) gene and protein in patients with severe AS stratified in high gradient (HG) and low flow-low gradient (LF-LG) AS and its association with cardiacfunctional impairments.
( A ) Univariable receiver operating characteristic (ROC) curves for all biomarkers. ( Abstract Aims Traditional cardiovascular (CV) biomarkers (high-sensitivity troponinT [hsTnT] and N-terminal pro-B-type natriuretic peptide [NT-proBNP]) are important to monitor cancer patients' cardiacfunction and to assess prognosis.
A strong positive correlation was also observed between Hcy levels and New York Heart Association (NYHA) classification (r=0.824, p<0.001).ConclusionsThe ConclusionsThe findings indicate that elevated plasma homocysteine is associated with myocardial remodeling and impaired diastolic function in HFpEF patients.
BackgroundThe complex relationship between insulin-like growth factor 1 (IGF-1) levels and heartfailure (HF) is not fully understood, particularly across different populations and conditions. Conversely, excessively high levels, as observed in acromegaly, are linked to a higher incidence of HF.
Detailed assessment of cardiacfunction after successful catheter ablation will reveal this. NT-proBNP levels were elevated in 18 (52.9%), and 16 reported ongoing heartfailure (HF) symptoms. 10 (29.4%) had no improvement in functional capacity, and seven (20.6%) showed persistent ventilatory inefficiency.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
45 
Let's personalize your content